421 related articles for article (PubMed ID: 28322854)
21. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
22. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
23. High Ki67 Expression has Prognostic Value in Surgically-Resected T3 Gastric Adenocarcinoma.
Huang G; Chen S; Wang D; Wang R; Lin L; Chen S; Wang L; Huang Q
Clin Lab; 2016; 62(1-2):141-53. PubMed ID: 27012044
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
26. TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer.
Chikaishi Y; Uramoto H; Koyanagi Y; Yamada S; Yano S; Tanaka F
Anticancer Res; 2016 Jan; 36(1):121-7. PubMed ID: 26722035
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
[TBL] [Abstract][Full Text] [Related]
28. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
29. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
30. Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Ann Thorac Surg; 2012 May; 93(5):1626-32. PubMed ID: 22421592
[TBL] [Abstract][Full Text] [Related]
31. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
32. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.
Keshari RP; Wang W; Zhang Y; Wang DD; Li YF; Yuan SQ; Qiu HB; Huang CY; Chen YM; Xia JC; Zhou ZW
PLoS One; 2014; 9(2):e87195. PubMed ID: 24504018
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
Zhang Z; Wang B; Huang G; Wang R; Song J; Lin S; Wang W; Jiang Y; Huang Q; Wang L
Clin Lab; 2017 Jan; 63(1):115-125. PubMed ID: 28164509
[TBL] [Abstract][Full Text] [Related]
35. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence.
Shimokawa H; Uramoto H; Onitsuka T; Chundong G; Hanagiri T; Oyama T; Yasumoto K
J Thorac Cardiovasc Surg; 2011 Apr; 141(4):895-8. PubMed ID: 21093878
[TBL] [Abstract][Full Text] [Related]
38. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
[TBL] [Abstract][Full Text] [Related]
39. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
40. The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.
He X; Zhou T; Yang G; Fang W; Li Z; Zhan J; Zhao Y; Cheng Z; Huang Y; Zhao H; Zhang L
Oncotarget; 2016 Mar; 7(12):15274-87. PubMed ID: 26933815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
